Cenobamate, sold under the brand names Xcopri (US) and Ontozry (EU), is a medication used for the treatment of partial-onset seizures, a kind of epilepsy, in adults. It is taken by mouth.[1][4][5]
Cenobamate was approved for medical use in the United States in November 2019[1][4][5][6] and placed in Schedule V of the Controlled Substances Act in March 2020.[7] Cenoba...
[wikipedia]
